DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Adacel (Tetanus Diphtheria Pertussis Vaccine) - Current Clinical Trials

 
 



Adacel Related Clinical Trials

Immunogenicity of Adacel� and BOOSTRIX� Vaccines in Adolescents [Completed]

Study of Adacel� Vaccine Administered to Persons 10 Years of Age [Completed]

Immune Responses in Adults to Revaccination With ADACEL� 10 Years After a Previous Dose [Completed]

Safety and Immunogenicity Study for Use of Menactra Versus Adacel in Subjects 11 to 55 Years of Age in South Korea [Completed]

A Study to Assess the Safety of Adacel Vaccine [Completed]

Safety and Immunogenicity in Adults of Revaccination With Adacel Vaccine 10 Years After a Previous Dose [Enrolling by invitation]

Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. [Completed]

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL) as a Booster in Adolescents [Completed]

Immunogenicity and Safety of Adacel Polio Vaccine [Completed]

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Active, not recruiting]

Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL Vaccine [Completed]

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age [Completed]

PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers [Completed]

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination. [Completed]

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age [Completed]

Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy [Completed]

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) [Completed]

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) [Completed]

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A [Completed]

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults [Completed]

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine [Completed]

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children [Completed]

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA [Completed]

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects [Completed]

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Completed]

NeisVac-C Single Prime Study in Infants [Completed]

Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers [Completed]

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine [Completed]

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine [Withdrawn]

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Recruiting]

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1) [Completed]

Baby Vaccine Study (Sched3) [Not yet recruiting]

Rates of Pertussis Disease Among Persons Receiving Pentacel or Other Pertussis Vaccines [Active, not recruiting]

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety [Completed]

Pertussis (Tdap) Vaccination in Pregnancy [Active, not recruiting]

An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster [Active, not recruiting]

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria [Completed]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Completed]

Pertussis Maternal Immunization Study [Active, not recruiting]

Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America [Completed]

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment [Completed]

Maternal Tdap Immunization in Guatemala [Not yet recruiting]

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants [Completed]

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients [Enrolling by invitation]

Comparison of Immunization Quality Improvement Dissemination Study [Completed]

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. [Completed]

DTaP and Apnea/Bradycardia in Preterm Infants [Completed]

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants [Completed]

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. [Terminated]

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants [Completed]

Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants [Completed]

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine [Completed]

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Completed]

Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib [Completed]

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers [Active, not recruiting]

Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis [Not yet recruiting]

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants [Completed]

Immunogenicity and Safety of Vaccinations in Immunocompromised Persons [Recruiting]

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules [Completed]

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Completed]

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Completed]

Pertussis Vaccine in Healthy Pregnant Women [Completed]

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants. [Completed]

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants [Completed]

A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants [Completed]

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Completed]

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs [Completed]

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age. [Completed]

PCV10 Reactogenicity and Immunogenicity Study - Malindi [Active, not recruiting]

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. [Completed]

Rotavirus Efficacy and Safety Trial (REST)(V260-006) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015